Endoplasmic reticulum stress related molecular mechanisms in nonalcoholic steatohepatitis

Mechanisms of Ageing and Development

Volumn 157, Issue , 2016, Pages 17-29

  Bozaykut, Perinur ^a   Sahin, Ali ^a   Karademir, Betul ^a   Ozer, Nesrin Kartal ^a  

^a MARMARA UNIVERSITY   (Turkey)

Author keywords

Endoplasmic reticulum stress; Hypercholesterolemia; MicroRNAs; Nonalcoholic steatohepatitis; Unfolded protein response

Indexed keywords

ABC TRANSPORTER; ACTIVATING TRANSCRIPTION FACTOR 6; CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A SYNTHASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LIVER X RECEPTOR ALPHA; LOW DENSITY LIPOPROTEIN RECEPTOR; MICRORNA; PROTEIN IRE1; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; SCAVENGER RECEPTOR BI; STEROL REGULATORY ELEMENT BINDING PROTEIN 2; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; X BOX BINDING PROTEIN 1;

AGING; APOPTOSIS; AUTOPHAGY; CHOLESTEROL METABOLISM; DISEASE ASSOCIATION; DISEASE COURSE; ENDOPLASMIC RETICULUM STRESS; GENE EXPRESSION; INFLAMMATION; INSULIN RESISTANCE; KUPFFER CELL; LIPID METABOLISM; LIPID STORAGE; LIPOPHAGOCYTOSIS; LIPOPROTEIN METABOLISM; LIVER CELL; NONALCOHOLIC FATTY LIVER; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN HOMEOSTASIS; REVIEW; STELLATE CELL; UNFOLDED PROTEIN RESPONSE; ANIMAL; HUMAN; METABOLISM; NON-ALCOHOLIC FATTY LIVER DISEASE; PATHOLOGY;

ANIMALS; APOPTOSIS; AUTOPHAGY; CHOLESTEROL; ENDOPLASMIC RETICULUM STRESS; HUMANS; INFLAMMATION; INSULIN RESISTANCE; NON-ALCOHOLIC FATTY LIVER DISEASE;

EID: 84978763686     PISSN: 00476374     EISSN: 18726216     Source Type: Journal    
DOI: 10.1016/j.mad.2016.07.001     Document Type: Review

References (204)

1. Adkins, Y., Schie, I.W., Fedor, D., Reddy, A., Nguyen, S., Zhou, P., et al. A novel mouse model of nonalcoholic steatohepatitis with significant insulin resistance. Lab. Invest. 93 (2013), 1313–1322.
2. Alberti, K.G., Eckel, R.H., Grundy, S.M., Zimmet, P.Z., Cleeman, J.I., Donato, K.A., et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120 (2009), 1640–1645.
3. Alisi, A., Da Sacco, S.L., Bruscalupi, G., Piemonte, F., Panera, N., De Vito, R., et al. Mirnome analysis reveals novel molecular determinants in the pathogenesis of diet-induced nonalcoholic fatty liver disease. Lab. Invest. 91 (2011), 283–293.
4. Arguello, G., Balboa, E., Arrese, M., Zanlungo, S., Recent insights on the role of cholesterol in non-alcoholic fatty liver disease. Biochim. Biophys. Acta 1852 (2015), 1765–1778.
5. Baffy, G., MicroRNAs in nonalcoholic fatty liver disease. J. Clin. Med. 4 (2015), 1977–1988.
6. Barreyro, F.J., Kobayashi, S., Bronk, S.F., Werneburg, N.W., Malhi, H., Gores, G.J., Transcriptional regulation of Bim by FoxO3A mediates hepatocyte lipoapoptosis. J. Biol. Chem. 282 (2007), 27141–27154.
7. Bartoszewski, R., Brewer, J.W., Rab, A., Crossman, D.K., Bartoszewska, S., Kapoor, N., et al. The unfolded protein response (UPR)-activated transcription factor X-box-binding protein 1 (XBP1) induces microRNA-346 expression that targets the human antigen peptide transporter 1 (TAP1) mRNA and governs immune regulatory genes. J. Biol. Chem. 286 (2011), 41862–41870.
8. Bechmann, L.P., Hannivoort, R.A., Gerken, G., Hotamisligil, G.S., Trauner, M., Canbay, A., The interaction of hepatic lipid and glucose metabolism in liver diseases. J. Hepatol. 56 (2012), 952–964.
9. Beg, Z.H., Stonik, J.A., Brewer, H.B. Jr., Phosphorylation of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase and modulation of its enzymic activity by calcium-activated and phospholipid-dependent protein kinase. J. Biol. Chem. 260 (1985), 1682–1687.
10. Beg, Z.H., Stonik, J.A., Brewer, H.B. Jr., Modulation of the enzymic activity of 3-hydroxy-3-methylglutaryl coenzyme A reductase by multiple kinase systems involving reversible phosphorylation: a review. Metabolism 36 (1987), 900–917.
11. Behrman, S., Acosta-Alvear, D., Walter, P., A CHOP-regulated microRNA controls rhodopsin expression. J. Cell Biol. 192 (2011), 919–927.
12. Belmont, P.J., Chen, W.J., Thuerauf, D.J., Glembotski, C.C., Regulation of microRNA expression in the heart by the ATF6 branch of the ER stress response. J. Mol. Cell. Cardiol. 52 (2012), 1176–1182.
13. Bertola, A., Bonnafous, S., Anty, R., Patouraux, S., Saint-Paul, M.C., Iannelli, A., et al. Hepatic expression patterns of inflammatory and immune response genes associated with obesity and NASH in morbidly obese patients. PLoS One, 5, 2010, e13577.
14. Bobrovnikova-Marjon, E., Hatzivassiliou, G., Grigoriadou, C., Romero, M., Cavener, D.R., Thompson, C.B., et al. PERK-dependent regulation of lipogenesis during mouse mammary gland development and adipocyte differentiation. Proc. Natl. Acad. Sci. U. S. A. 105 (2008), 16314–16319.
15. Bogdanovic, E., Kraus, N., Patsouris, D., Diao, L., Wang, V., Abdullahi, A., et al. Endoplasmic reticulum stress in adipose tissue augments lipolysis. J. Cell. Mol. Med. 19 (2015), 82–91.
16. Bozaykut, P., Karademir, B., Yazgan, B., Sozen, E., Siow, R.C., Mann, G.E., et al. Effects of vitamin E on peroxisome proliferator-activated receptor gamma and nuclear factor-erythroid 2-related factor 2 in hypercholesterolemia-induced atherosclerosis. Free Radic. Biol. Med. 70 (2014), 174–181.
17. Bravo, R., Gutierrez, T., Paredes, F., Gatica, D., Rodriguez, A.E., Pedrozo, Z., et al. Endoplasmic reticulum: ER stress regulates mitochondrial bioenergetics. Int J. Biochem. Cell Biol. 44 (2012), 16–20.
18. Bugianesi, E., Non-alcoholic steatohepatitis and cancer. Clin. Liver Dis. 11 (2007), 191–207.
19. Caballero, F., Fernandez, A., De Lacy, A.M., Fernandez-Checa, J.C., Caballeria, J., Garcia-Ruiz, C., Enhanced free cholesterol, SREBP-2 and StAR expression in human NASH. J. Hepatol. 50 (2009), 789–796.
20. Canto, C., Auwerx, J., Targeting sirtuin 1 to improve metabolism: all you need is NAD(+)?. Pharmacol. Rev. 64 (2012), 166–187.
21. Carthew, R.W., Sontheimer, E.J., Origins and Mechanisms of miRNAs and siRNAs. Cell 136 (2009), 642–655.
22. Castro, R.E., Ferreira, D.M., Afonso, M.B., Borralho, P.M., Machado, M.V., Cortez-Pinto, H., et al. miR-34a/SIRT1/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease. J. Hepatol. 58 (2013), 119–125.
23. Cazanave, S.C., Mott, J.L., Elmi, N.A., Bronk, S.F., Werneburg, N.W., Akazawa, Y., et al. JNK1-dependent PUMA expression contributes to hepatocyte lipoapoptosis. J. Biol. Chem. 284 (2009), 26591–26602.
24. Cazanave, S.C., Elmi, N.A., Akazawa, Y., Bronk, S.F., Mott, J.L., Gores, G.J., CHOP and AP-1 cooperatively mediate PUMA expression during lipoapoptosis. Am J. Physiol. Gastrointest. Liver Physiol. 299 (2010), G236–G243.
25. Cermelli, S., Ruggieri, A., Marrero, J.A., Ioannou, G.N., Beretta, L., Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease. PLoS One, 6, 2011, e23937.
26. Chapados, N.A., Lavoie, J.M., Exercise training increases hepatic endoplasmic reticulum (er) stress protein expression in MTP-inhibited high-fat fed rats. Cell Biochem. Funct. 28 (2010), 202–210.
27. Cheung, O., Puri, P., Eicken, C., Contos, M.J., Mirshahi, F., Maher, J.W., et al. Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression. Hepatology 48 (2008), 1810–1820.
28. Chitnis, N.S., Pytel, D., Bobrovnikova-Marjon, E., Pant, D., Zheng, H., Maas, N.L., et al. miR-211 is a prosurvival microRNA that regulates chop expression in a PERK-dependent manner. Mol. Cell 48 (2012), 353–364.
29. Choi, S.E., Fu, T., Seok, S., Kim, D.H., Yu, E., Lee, K.W., et al. Elevated microRNA-34a in obesity reduces NAD+ levels and SIRT1 activity by directly targeting NAMPT. Aging Cell 12 (2013), 1062–1072.
30. Chowdhry, S., Nazmy, M.H., Meakin, P.J., Dinkova-Kostova, A.T., Walsh, S.V., Tsujita, T., et al. Loss of Nrf2 markedly exacerbates nonalcoholic steatohepatitis. Free Radic. Biol. Med. 48 (2010), 357–371.
31. Cohen, D.E., Fisher, E.A., Lipoprotein metabolism, dyslipidemia, and nonalcoholic fatty liver disease. Semin. Liver Dis. 33 (2013), 380–388.
32. Cohen, J.C., Horton, J.D., Hobbs, H.H., Human fatty liver disease: old questions and new insights. Science 332 (2011), 1519–1523.
33. Corey, K.E., Chalasani, N., Management of dyslipidemia as a cardiovascular risk factor in individuals with nonalcoholic fatty liver disease. Clin. Gastroenterol. Hepatol. 12 (2014), 1077–1084.
34. Cortes, V.A., Busso, D., Maiz, A., Arteaga, A., Nervi, F., Rigotti, A., Physiological and pathological implications of cholesterol. Front. Biosci. (Landmark Ed.) 19 (2014), 416–428.
35. Cortez, M.A., Bueso-Ramos, C., Ferdin, J., Lopez-Berestein, G., Sood, A.K., Calin, G.A., MicroRNAs in body fluids?the mix of hormones and biomarkers. Nat. Rev. Clin. Oncol. 8 (2011), 467–477.
36. Cortez-Pinto, H., Chatham, J., Chacko, V.P., Arnold, C., Rashid, A., Diehl, A.M., Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis: a pilot study. JAMA 282 (1999), 1659–1664.
37. Cortez-Pinto, H., de Moura, M.C., Day, C.P., Non-alcoholic steatohepatitis: from cell biology to clinical practice. J. Hepatol. 44 (2006), 197–208.
38. Csala, M., Margittai, E., Banhegyi, G., Redox control of endoplasmic reticulum function. Antioxid. Redox Signal. 13 (2010), 77–108.
39. Cullinan, S.B., Diehl, J.A., PERK-dependent activation of Nrf2 contributes to redox homeostasis and cell survival following endoplasmic reticulum stress. J. Biol. Chem. 279 (2004), 20108–20117.
40. Cullinan, S.B., Diehl, J.A., Coordination of ER and oxidative stress signaling: the PERK/Nrf2 signaling pathway. Int. J. Biochem. Cell Biol. 38 (2006), 317–332.
41. Cullinan, S.B., Zhang, D., Hannink, M., Arvisais, E., Kaufman, R.J., Diehl, J.A., Nrf2 is a direct PERK substrate and effector of PERK-dependent cell survival. Mol. Cell. Biol. 23 (2003), 7198–7209.
42. Czaja, M.J., Ding, W.X., Donohue, T.M., Friedman, S.L., Kim, J.S., Komatsu, M., et al. Functions of autophagy in normal and diseased liver. Autophagy 9 (2013), 1131–1158.
43. Dai, B.H., Geng, L., Wang, Y., Sui, C.J., Xie, F., Shen, R.X., et al. microRNA-199a-5p protects hepatocytes from bile acid-induced sustained endoplasmic reticulum stress. Cell. Death. Dis., 4, 2013, e604.
44. Day, C.P., Genetic and environmental susceptibility to non-alcoholic fatty liver disease. Dig. Dis. 28 (2010), 255–260.
45. De, M.S., Day, C., Svegliati-Baroni, G., From NAFLD to NASH and HCC: pathogenetic mechanisms and therapeutic insights. Curr. Pharm. Des. 19 (2013), 5239–5249.
46. Dela, P.A., Leclercq, I., Field, J., George, J., Jones, B., Farrell, G., NF-kappaB activation, rather than TNF, mediates hepatic inflammation in a murine dietary model of steatohepatitis. Gastroenterology 129 (2005), 1663–1674.
47. Deng, J., Lu, P.D., Zhang, Y., Scheuner, D., Kaufman, R.J., Sonenberg, N., et al. Translational repression mediates activation of nuclear factor kappa B by phosphorylated translation initiation factor 2. Mol. Cell. Biol. 24 (2004), 10161–10168.
48. Ding, W.X., Role of autophagy in liver physiology and pathophysiology. World J. Biol. Chem. 1 (2010), 3–12.
49. Diraison, F., Moulin, P., Beylot, M., Contribution of hepatic de novo lipogenesis and reesterification of plasma non esterified fatty acids to plasma triglyceride synthesis during non-alcoholic fatty liver disease. Diabetes Metab. 29 (2003), 478–485.
50. Eckel, R.H., Grundy, S.M., Zimmet, P.Z., The metabolic syndrome. Lancet 365 (2005), 1415–1428.
51. Egnatchik, R.A., Leamy, A.K., Jacobson, D.A., Shiota, M., Young, J.D., ER calcium release promotes mitochondrial dysfunction and hepatic cell lipotoxicity in response to palmitate overload. Mol. Metab. 3 (2014), 544–553.
52. Enjoji, M., Yasutake, K., Kohjima, M., Nakamuta, M., Nutrition and nonalcoholic Fatty liver disease: the significance of cholesterol. Int. J. Hepatol., 2012, 925807.
53. Esau, C., Davis, S., Murray, S.F., Yu, X.X., Pandey, S.K., Pear, M., et al. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab. 3 (2006), 87–98.
54. Fabbrini, E., Magkos, F., Hepatic steatosis as a marker of metabolic dysfunction. Nutrients 7 (2015), 4995–5019.
55. Fabbrini, E., Mohammed, B.S., Magkos, F., Korenblat, K.M., Patterson, B.W., Klein, S., Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease. Gastroenterology 134 (2008), 424–431.
56. Feldstein, A.E., Canbay, A., Angulo, P., Taniai, M., Burgart, L.J., Lindor, K.D., et al. Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis. Gastroenterology 125 (2003), 437–443.
57. Feldstein, A.E., Werneburg, N.W., Canbay, A., Guicciardi, M.E., Bronk, S.F., Rydzewski, R., et al. Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway. Hepatology 40 (2004), 185–194.
58. Festi, D., Colecchia, A., Sacco, T., Bondi, M., Roda, E., Marchesini, G., Hepatic steatosis in obese patients: clinical aspects and prognostic significance. Obes. Rev. 5 (2004), 27–42.
59. Fon, T.K., Rozman, D., Nonalcoholic Fatty liver disease: focus on lipoprotein and lipid deregulation. J. Lipids, 2011, 2011, 783976.
60. Fritz, R., Bol, J., Hebling, U., Angermuller, S., Volkl, A., Fahimi, H.D., et al. Compartment-dependent management of H(2)O(2) by peroxisomes. Free Radic. Biol. Med. 42 (2007), 1119–1129.
61. Fu, S., Yang, L., Li, P., Hofmann, O., Dicker, L., Hide, W., et al. Aberrant lipid metabolism disrupts calcium homeostasis causing liver endoplasmic reticulum stress in obesity. Nature 473 (2011), 528–531.
62. Fu, S., Watkins, S.M., Hotamisligil, G.S., The role of endoplasmic reticulum in hepatic lipid homeostasis and stress signaling. Cell Metab. 15 (2012), 623–634.
63. Fuchs, M., Sanyal, A.J., Lipotoxicity in NASH. J. Hepatol. 56 (2012), 291–293.
64. Geisler, F., Algul, H., Paxian, S., Schmid, R.M., Genetic inactivation of RelA/p65 sensitizes adult mouse hepatocytes to TNF-induced apoptosis in vivo and in vitro. Gastroenterology 132 (2007), 2489–2503.
65. Gentile, C.L., Pagliassotti, M.J., The role of fatty acids in the development and progression of nonalcoholic fatty liver disease. J. Nutr. Biochem. 19 (2008), 567–576.
66. Ghildiyal, M., Zamore, P.D., Small silencing RNAs: an expanding universe. Nat. Rev. Genet. 10 (2009), 94–108.
67. Goedeke, L., Vales-Lara, F.M., Fenstermaker, M., Cirera-Salinas, D., Chamorro-Jorganes, A., Ramirez, C.M., et al. A regulatory role for microRNA 33* in controlling lipid metabolism gene expression. Mol. Cell. Biol. 33 (2013), 2339–2352.
68. Gonzalez-Rodriguez, A., Mayoral, R., Agra, N., Valdecantos, M.P., Pardo, V., Miquilena-Colina, M.E., et al. Impaired autophagic flux is associated with increased endoplasmic reticulum stress during the development of NAFLD. Cell. Death. Dis., 5, 2014.
69. Gracia-Sancho, J., Guixe-Muntet, S., Hide, D., Bosch, J., Modulation of autophagy for the treatment of liver diseases. Expert Opin. Investig. Drugs 23 (2014), 965–977.
70. Gregor, M.F., Hotamisligil, G.S., Thematic review series: adipocyte biology. Adipocyte stress: the endoplasmic reticulum and metabolic disease. J. Lipid Res. 48 (2007), 1905–1914.
71. Gupte, A.A., Lyon, C.J., Hsueh, W.A., Nuclear factor (erythroid-derived 2)-like-2 factor (Nrf2), a key regulator of the antioxidant response to protect against atherosclerosis and nonalcoholic steatohepatitis. Curr. Diabetes Rep. 13 (2013), 362–371.
72. Hager, L., Li, L., Pun, H., Liu, L., Hossain, M.A., Maguire, G.F., et al. Lecithin:cholesterol acyltransferase deficiency protects against cholesterol-induced hepatic endoplasmic reticulum stress in mice. J. Biol. Chem. 287 (2012), 20755–20768.
73. Hamanaka, R.B., Bobrovnikova-Marjon, E., Ji, X., Liebhaber, S.A., Diehl, J.A., PERK-dependent regulation of IAP translation during ER stress. Oncogene 28 (2009), 910–920.
74. Hayes, J.D., Dinkova-Kostova, A.T., The Nrf2 regulatory network provides an interface between redox and intermediary metabolism. Trends Biochem. Sci. 39 (2014), 199–218.
75. Hetz, C., Glimcher, L.H., Fine-tuning of the unfolded protein response: assembling the IRE1alpha interactome. Mol. Cell 35 (2009), 551–561.
76. Hetz, C., Bernasconi, P., Fisher, J., Lee, A.H., Bassik, M.C., Antonsson, B., et al. Proapoptotic BAX and BAK modulate the unfolded protein response by a direct interaction with IRE1alpha. Science 312 (2006), 572–576.
77. Higa, A., Chevet, E., Redox signaling loops in the unfolded protein response. Cell. Signal. 24 (2012), 1548–1555.
78. Hoekstra, M., van der Sluis, R.J., Kuiper, J., Van Berkel, T.J., Nonalcoholic fatty liver disease is associated with an altered hepatocyte microRNA profile in LDL receptor knockout mice. J. Nutr. Biochem. 23 (2012), 622–628.
79. Horton, J.D., Goldstein, J.L., Brown, M.S., SREBPs activators of the complete program of cholesterol and fatty acid synthesis in the liver. J. Clin. Invest. 109 (2002), 1125–1131.
80. Hotamisligil, G.S., Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell 140 (2010), 900–917.
81. Hsu, C.C., Schwabe, R.F., Autophagy and hepatic stellate cell activation – Partners in crime?. J. Hepatol. 55 (2011), 1176–1177.
82. Hu, P., Han, Z., Couvillon, A.D., Kaufman, R.J., Exton, J.H., Autocrine tumor necrosis factor alpha links endoplasmic reticulum stress to the membrane death receptor pathway through IRE1alpha-mediated NF-kappaB activation and down-regulation of TRAF2 expression. Mol. Cell. Biol. 26 (2006), 3071–3084.
83. Hui, J.M., Hodge, A., Farrell, G.C., Kench, J.G., Kriketos, A., George, J., Beyond insulin resistance in NASH: TNF-alpha or adiponectin?. Hepatology 40 (2004), 46–54.
84. Jiang, H.Y., Wek, S.A., McGrath, B.C., Scheuner, D., Kaufman, R.J., Cavener, D.R., et al. Phosphorylation of the alpha subunit of eukaryotic initiation factor 2 is required for activation of NF-kappaB in response to diverse cellular stresses. Mol. Cell. Biol. 23 (2003), 5651–5663.
85. Kalaany, N.Y., Mangelsdorf, D.J., LXRS and FXR: the yin and yang of cholesterol and fat metabolism. Annu. Rev. Physiol. 68 (2006), 159–191.
86. Kammoun, H.L., Chabanon, H., Hainault, I., Luquet, S., Magnan, C., Koike, T., et al. GRP78 expression inhibits insulin and ER stress-induced SREBP-1c activation and reduces hepatic steatosis in mice. J. Clin. Invest. 119 (2009), 1201–1215.
87. Kaplowitz, N., Than, T.A., Shinohara, M., Ji, C., Endoplasmic reticulum stress and liver injury. Semin. Liver Dis. 27 (2007), 367–377.
88. Kaufman, R.J., Back, S.H., Song, B., Han, J., Hassler, J., The un folded protein response is required to maintain the integrity of the endoplasmic reticulum, prevent oxidative stress and preserve differentiation in beta-cells. Diabetes Obes. Metab. 12:Suppl. 2 (2010), 99–107.
89. Kaufman, R.J., Stress signaling from the lumen of the endoplasmic reticulum: coordination of gene transcriptional and translational controls. Genes Dev. 13 (1999), 1211–1233.
90. Kawai, D., Takaki, A., Nakatsuka, A., Wada, J., Tamaki, N., Yasunaka, T., et al. Hydrogen-rich water prevents progression of nonalcoholic steatohepatitis and accompanying hepatocarcinogenesis in mice. Hepatology 56 (2012), 912–921.
91. Khan, T., Hamilton, M.P., Mundy, D.I., Chua, S.C., Scherer, P.E., Impact of simvastatin on adipose tissue: pleiotropic effects in vivo. Endocrinology 150 (2009), 5262–5272.
92. Kim, I., Xu, W., Reed, J.C., Cell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunities. Nat. Rev. Drug Discov. 7 (2008), 1013–1030.
93. Kleiner, D.E., Brunt, E.M., Nonalcoholic fatty liver disease: pathologic patterns and biopsy evaluation in clinical research. Semin. Liver Dis. 32 (2012), 3–13.
94. Kraskiewicz, H., FitzGerald, U., InterfERing with endoplasmic reticulum stress. Trends Pharmacol. Sci. 33 (2012), 53–63.
95. Krutzfeldt, J., Rajewsky, N., Braich, R., Rajeev, K.G., Tuschl, T., Manoharan, M., et al. Silencing of microRNAs in vivo with ‘antagomirs’. Nature 438 (2005), 685–689.
96. Lake, A.D., Novak, P., Hardwick, R.N., Flores-Keown, B., Zhao, F., Klimecki, W.T., et al. The adaptive endoplasmic reticulum stress response to lipotoxicity in progressive human nonalcoholic fatty liver disease. Toxicol. Sci. 137 (2014), 26–35.
97. Leamy, A.K., Egnatchik, R.A., Shiota, M., Ivanova, P.T., Myers, D.S., Brown, H.A., et al. Enhanced synthesis of saturated phospholipids is associated with ER stress and lipotoxicity in palmitate treated hepatic cells. J. Lipid Res. 55 (2014), 1478–1488.
98. Lee, J., Ozcan, U., Unfolded protein response signaling and metabolic diseases. J. Biol. Chem. 289 (2014), 1203–1211.
99. Lee, A.H., Scapa, E.F., Cohen, D.E., Glimcher, L.H., Regulation of hepatic lipogenesis by the transcription factor XBP1. Science 320 (2008), 1492–1496.
100. Lee, J.S., Zheng, Z., Mendez, R., Ha, S.W., Xie, Y., Zhang, K., Pharmacologic ER. stress induces non-alcoholic steatohepatitis in an animal model. Toxicol. Lett. 211 (2012), 29–38.
101. Lee, K.W., Thiyagarajan, V., Sie, H.W., Cheng, M.F., Tsai, M.J., Chia, Y.C., et al. Synergistic effect of natural compounds on the fatty acid-induced autophagy of activated hepatic stellate cells. J. Nutr. Biochem. 25 (2014), 903–913.
102. Lewis, A.P., Jopling, C.L., Regulation and biological function of the liver-specific miR-122. Biochem. Soc. Trans. 38 (2010), 1553–1557.
103. Lewis, B.P., Burge, C.B., Bartel, D.P., Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120 (2005), 15–20.
104. Li, Y., Ge, M., Ciani, L., Kuriakose, G., Westover, E.J., Dura, M., et al. Enrichment of endoplasmic reticulum with cholesterol inhibits sarcoplasmic-endoplasmic reticulum calcium ATPase-2b activity in parallel with increased order of membrane lipids: implications for depletion of endoplasmic reticulum calcium stores and apoptosis in cholesterol-loaded macrophages. J. Biol. Chem. 279 (2004), 37030–37039.
105. Li, T., Kong, X., Owsley, E., Ellis, E., Strom, S., Chiang, J.Y., Insulin regulation of cholesterol 7alpha-hydroxylase expression in human hepatocytes: roles of forkhead box O1 and sterol regulatory element-binding protein 1c. J. Biol. Chem. 281 (2006), 28745–28754.
106. Li, G., Mongillo, M., Chin, K.T., Harding, H., Ron, D., Marks, A.R., et al. Role of ERO1-alpha-mediated stimulation of inositol 1,4,5-triphosphate receptor activity in endoplasmic reticulum stress-induced apoptosis. J. Cell Biol. 186 (2009), 783–792.
107. Lim, J.H., Lee, H.J., Ho, J.M., Song, J., Coupling mitochondrial dysfunction to endoplasmic reticulum stress response: a molecular mechanism leading to hepatic insulin resistance. Cell. Signal. 21 (2009), 169–177.
108. Liu, H., Lo, C.R., Czaja, M.J., NF-kappaB inhibition sensitizes hepatocytes to TNF-induced apoptosis through a sustained activation of JNK and c-Jun. Hepatology 35 (2002), 772–778.
109. Liu, Y., Adachi, M., Zhao, S., Hareyama, M., Koong, A.C., Luo, D., et al. Preventing oxidative stress: a new role for XBP1. Cell Death Differ. 16 (2009), 847–857.
110. Luciani, D.S., Gwiazda, K.S., Yang, T.L., Kalynyak, T.B., Bychkivska, Y., Frey, M.H., et al. Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death. Diabetes 58 (2009), 422–432.
111. Luedde, T., Beraza, N., Kotsikoris, V., van, L.G., Nenci, A., De, V.R., et al. Deletion of NEMO/IKKgamma in liver parenchymal cells causes steatohepatitis and hepatocellular carcinoma. Cancer Cell 11 (2007), 119–132.
112. Luu, W., Sharpe, L.J., Gelissen, I.C., Brown, A.J., The role of signalling in cellular cholesterol homeostasis. IUBMB Life 65 (2013), 675–684.
113. Ma, D., Liu, W., Wang, Y., ApoA-I or ABCA1 expression suppresses fatty acid synthesis by reducing 27-hydroxycholesterol levels. Biochimie 103 (2014), 101–108.
114. Malhi, H., Kaufman, R.J., Endoplasmic reticulum stress in liver disease. J. Hepatol. 54 (2011), 795–809.
115. Malhi, H., Kropp, E.M., Clavo, V.F., Kobrossi, C.R., Han, J., Mauer, A.S., et al. C/EBP homologous protein-induced macrophage apoptosis protects mice from steatohepatitis. J. Biol. Chem. 288 (2013), 18624–18642.
116. Malhi, H., MicroRNAs in ER stress: divergent roles in cell fate decisions. Curr. Pathobiol. Rep. 2 (2014), 117–122.
117. Malhotra, J.D., Kaufman, R.J., Endoplasmic reticulum stress and oxidative stress: a vicious cycle or a double-edged sword?. Antioxid. Redox Signal. 9 (2007), 2277–2294.
118. Maqbool, R., Ul Hussain, M., MicroRNAs and human diseases: diagnostic and therapeutic potential. Cell Tissue Res. 358 (2014), 1–15.
119. Marciniak, S.J., Yun, C.Y., Oyadomari, S., Novoa, I., Zhang, Y., Jungreis, R., et al. CHOP induces death by promoting protein synthesis and oxidation in the stressed endoplasmic reticulum. Genes Dev. 18 (2004), 3066–3077.
120. Mari, M., Caballero, F., Colell, A., Morales, A., Caballeria, J., Fernandez, A., et al. Mitochondrial free cholesterol loading sensitizes to TNF- and Fas-mediated steatohepatitis. Cell Metab. 4 (2006), 185–198.
121. Mehrpour, M., Esclatine, A., Beau, I., Codogno, P., Autophagy in health and disease. 1. Regulation and significance of autophagy: an overview. Am. J. Physiol. Cell Physiol. 298 (2010), C776–C785.
122. Mei, S., Ni, H.M., Manley, S., Bockus, A., Kassel, K.M., Luyendyk, J.P., et al. Differential roles of unsaturated and saturated fatty acids on autophagy and apoptosis in hepatocytes. J. Pharmacol. Exp. Ther. 339 (2011), 487–498.
123. Milic, S., Stimac, D., Nonalcoholic fatty liver disease/steatohepatitis: epidemiology, pathogenesis, clinical presentation and treatment. Dig. Dis. 30 (2012), 158–162.
124. Miller, A.M., Gilchrist, D.S., Nijjar, J., Araldi, E., Ramirez, C.M., Lavery, C.A., et al. MiR-155 has a protective role in the development of non-alcoholic hepatosteatosis in mice. PLoS One, 8, 2013, e72324.
125. Min, H.K., Kapoor, A., Fuchs, M., Mirshahi, F., Zhou, H., Maher, J., et al. Increased hepatic synthesis and dysregulation of cholesterol metabolism is associated with the severity of nonalcoholic fatty liver disease. Cell Metab. 15 (2012), 665–674.
126. Miquilena-Colina, M.E., Lima-Cabello, E., Sanchez-Campos, S., Garcia-Mediavilla, M.V., Fernandez-Bermejo, M., Lozano-Rodriguez, T., et al. Hepatic fatty acid translocase CD36 upregulation is associated with insulin resistance, hyperinsulinaemia and increased steatosis in non-alcoholic steatohepatitis and chronic hepatitis C. Gut 60 (2011), 1394–1402.
127. Musso, G., Gambino, R., Cassader, M., Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD). Prog. Lipid Res. 48 (2009), 1–26.
128. Musso, G., Gambino, R., Pacini, G., De Michieli, F., Cassader, M., Prolonged saturated fat-induced, glucose-dependent insulinotropic polypeptide elevation is associated with adipokine imbalance and liver injury in nonalcoholic steatohepatitis: dysregulated enteroadipocyte axis as a novel feature of fatty liver. Am. J. Clin. Nutr. 89 (2009), 558–567.
129. Nguyen, D.T., Kebache, S., Fazel, A., Wong, H.N., Jenna, S., Emadali, A., et al. Nck-dependent activation of extracellular signal-regulated kinase-1 and regulation of cell survival during endoplasmic reticulum stress. Mol. Biol. Cell 15 (2004), 4248–4260.
130. Oakes, S.A., Scorrano, L., Opferman, J.T., Bassik, M.C., Nishino, M., Pozzan, T., et al. Proapoptotic BAX and BAK regulate the type 1 inositol trisphosphate receptor and calcium leak from the endoplasmic reticulum. Proc. Natl. Acad. Sci. U. S. A. 102 (2005), 105–110.
131. Ogawa, T., Enomoto, M., Fujii, H., Sekiya, Y., Yoshizato, K., Ikeda, K., et al. MicroRNA-221/222 upregulation indicates the activation of stellate cells and the progression of liver fibrosis. Gut 61 (2012), 1600–1609.
132. Okada, K., Warabi, E., Sugimoto, H., Horie, M., Tokushige, K., Ueda, T., et al. Nrf2 inhibits hepatic iron accumulation and counteracts oxidative stress-induced liver injury in nutritional steatohepatitis. J. Gastroenterol. 47 (2012), 924–935.
133. Oyadomari, S., Harding, H.P., Zhang, Y., Oyadomari, M., Ron, D., Dephosphorylation of translation initiation factor 2alpha enhances glucose tolerance and attenuates hepatosteatosis in mice. Cell Metab. 7 (2008), 520–532.
134. Ozcan, U., Cao, Q., Yilmaz, E., Lee, A.H., Iwakoshi, N.N., Ozdelen, E., et al. Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 306 (2004), 457–461.
135. Pagliassotti, M.J., Endoplasmic reticulum stress in nonalcoholic fatty liver disease. Annu. Rev. Nutr. 32 (2012), 17–33.
136. Pahl, H.L., Baeuerle, P.A., A novel signal transduction pathway from the endoplasmic reticulum to the nucleus is mediated by transcription factor NF-kappa B. EMBO J. 14 (1995), 2580–2588.
137. Park, S.W., Zhou, Y., Lee, J., Lee, J., Ozcan, U., Sarco(endo)plasmic reticulum Ca2+-ATPase 2b is a major regulator of endoplasmic reticulum stress and glucose homeostasis in obesity. Proc. Natl. Acad. Sci. U. S. A. 107 (2010), 19320–19325.
138. Park, E.J., Lee, A.Y., Park, S., Kim, J.H., Cho, M.H., Multiple pathways are involved in palmitic acid-induced toxicity. Food Chem. Toxicol. 67 (2014), 26–34.
139. Pessayre, D., Role of mitochondria in non-alcoholic fatty liver disease. J. Gastroenterol. Hepatol. 22:Suppl. 1 (2007), S20–S27.
140. Pfaffenbach, K.T., Gentile, C.L., Nivala, A.M., Wang, D., Wei, Y., Pagliassotti, M.J., Linking endoplasmic reticulum stress to cell death in hepatocytes: roles of C/EBP homologous protein and chemical chaperones in palmitate-mediated cell death. Am. J. Physiol. Endocrinol. Metab. 298 (2010), E1027–E1035.
141. Pizarro, M., Balasubramaniyan, N., Solis, N., Solar, A., Duarte, I., Miquel, J.F., et al. Bile secretory function in the obese Zucker rat: evidence of cholestasis and altered canalicular transport function. Gut 53 (2004), 1837–1843.
142. Pogribny, I.P., Starlard-Davenport, A., Tryndyak, V.P., Han, T., Ross, S.A., Rusyn, I., et al. Difference in expression of hepatic microRNAs miR-29c, miR-34a, miR-155, and miR-200b is associated with strain-specific susceptibility to dietary nonalcoholic steatohepatitis in mice. Lab. Invest. 90 (2010), 1437–1446.
143. Premoli, A., Paschetta, E., Hvalryg, M., Spandre, M., Bo, S., Durazzo, M., Characteristics of liver diseases in the elderly: a review. Minerva Gastroenterol. Dietol. 55 (2009), 71–78.
144. Rayner, K.J., Suarez, Y., Davalos, A., Parathath, S., Fitzgerald, M.L., Tamehiro, N., et al. MiR-33 contributes to the regulation of cholesterol homeostasis. Science 328 (2010), 1570–1573.
145. Rolo, A.P., Teodoro, J.S., Palmeira, C.M., Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis. Free Radic. Biol. Med. 52 (2012), 59–69.
146. Ron, D., Walter, P., Signal integration in the endoplasmic reticulum unfolded protein response. Nat. Rev. Mol. Cell Biol. 8 (2007), 519–529.
147. Rottiers, V., Naar, A.M., MicroRNAs in metabolism and metabolic disorders. Nat. Rev. Mol. Cell Biol. 13 (2012), 239–250.
148. Santos, C.X., Tanaka, L.Y., Wosniak, J., Laurindo, F.R., Mechanisms and implications of reactive oxygen species generation during the unfolded protein response: roles of endoplasmic reticulum oxidoreductases, mitochondrial electron transport, and NADPH oxidase. Antioxid. Redox Signal. 11 (2009), 2409–2427.
149. Sayed, D., Abdellatif, M., MicroRNAs in development and disease. Physiol. Rev. 91 (2011), 827–887.
150. Schroder, M., Kaufman, R.J., The mammalian unfolded protein response. Annu. Rev. Biochem. 74 (2005), 739–789.
151. Scorrano, L., Oakes, S.A., Opferman, J.T., Cheng, E.H., Sorcinelli, M.D., Pozzan, T., et al. BAX and BAK regulation of endoplasmic reticulum Ca2+: a control point for apoptosis. Science 300 (2003), 135–139.
152. Seo, J., Fortuno, E.S., Suh, J.M. III, Stenesen, D., Tang, W., Parks, E.J., et al. Atf4 regulates obesity, glucose homeostasis and energy expenditure. Diabetes 58 (2009), 2565–2573.
153. Serviddio, G., Bellanti, F., Tamborra, R., Rollo, T., Romano, A.D., Giudetti, A.M., et al. Alterations of hepatic ATP homeostasis and respiratory chain during development of non-alcoholic steatohepatitis in a rodent model. Eur. J. Clin. Invest. 38 (2008), 245–252.
154. Shimozono, R., Asaoka, Y., Yoshizawa, Y., Aoki, T., Noda, H., Yamada, M., et al. Nrf2 activators attenuate the progression of nonalcoholic steatohepatitis-related fibrosis in a dietary rat model. Mol. Pharmacol. 84 (2013), 62–70.
155. Siddiqui, M.S., Fuchs, M., Idowu, M.O., Luketic, V.A., Boyett, S., Sargeant, C., et al. Severity of nonalcoholic fatty liver disease and progression to cirrhosis are associated with atherogenic lipoprotein profile. Clin. Gastroenterol. Hepatol. 13 (2015), 1000–1008.e3.
156. Simonen, P., Kotronen, A., Hallikainen, M., Sevastianova, K., Makkonen, J., Hakkarainen, A., et al. Cholesterol synthesis is increased and absorption decreased in non-alcoholic fatty liver disease independent of obesity. J. Hepatol. 54 (2011), 153–159.
157. Singh, R., Cuervo, A.M., Autophagy in the cellular energetic balance. Cell Metab. 13 (2011), 495–504.
158. Singh, S.C., Macdonald, K.C., Mantle skewness and ridge segmentation. Nature 458 (2009), E11–E12.
159. Singh, R., Kaushik, S., Wang, Y.J., Xiang, Y.Q., Novak, I., Komatsu, M., et al. Autophagy regulates lipid metabolism. Nature 458 (2009), 1131–1135.
160. Sinha, R.A., You, S.H., Zhou, J., Siddique, M.M., Bay, B.H., Zhu, X.G., et al. Thyroid hormone stimulates hepatic lipid catabolism via activation of autophagy. J. Clin. Invest. 122 (2012), 2428–2438.
161. Sinha, R.A., Farah, B.L., Singh, B.K., Siddique, M.M., Li, Y., Wu, Y.J., et al. Caffeine stimulates hepatic lipid metabolism by the autophagy-lysosomal pathway in mice. Hepatology 59 (2014), 1366–1380.
162. Spolding, B., Connor, T., Wittmer, C., Abreu, L.L., Kaspi, A., Ziemann, M., et al. Rapid development of non-alcoholic steatohepatitis in Psammomys obesus (Israeli sand rat). PLoS One, 9, 2014, e92656.
163. Su, K., Sabeva, N.S., Liu, J., Wang, Y., Bhatnagar, S., van der Westhuyzen, D.R., et al. The ABCG5 ABCG8 sterol transporter opposes the development of fatty liver disease and loss of glycemic control independently of phytosterol accumulation. J. Biol. Chem. 287 (2012), 28564–28575.
164. Su, K., Sabeva, N.S., Wang, Y., Liu, X., Lester, J.D., Liu, J., et al. Acceleration of biliary cholesterol secretion restores glycemic control and alleviates hypertriglyceridemia in obese db/db mice. Arterioscler. Thromb. Vasc. Biol. 34 (2014), 26–33.
165. Sugimoto, H., Okada, K., Shoda, J., Warabi, E., Ishige, K., Ueda, T., et al. Deletion of nuclear factor-E2-related factor-2 leads to rapid onset and progression of nutritional steatohepatitis in mice. Am. J. Physiol. Gastrointest. Liver Physiol. 298 (2010), G283–G294.
166. Takaki, A., Kawai, D., Yamamoto, K., Molecular mechanisms and new treatment strategies for non-alcoholic steatohepatitis (NASH). Int. J. Mol. Sci. 15 (2014), 7352–7379.
167. Thoen, L.F., Guimaraes, E.L., Dolle, L., Mannaerts, I., Najimi, M., Sokal, E., et al. A role for autophagy during hepatic stellate cell activation. J. Hepatol. 55 (2011), 1353–1360.
168. Tilg, H., Moschen, A.R., Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology 52 (2010), 1836–1846.
169. Tran, K.Q., Graewin, S.J., Swartz-Basile, D.A., Nakeeb, A., Svatek, C.L., Pitt, H.A., Leptin-resistant obese mice have paradoxically low biliary cholesterol saturation. Surgery 134 (2003), 372–377.
170. Tsai, Y.C., Weissman, A.M., The unfolded protein response, degradation from endoplasmic reticulum and cancer. Genes Cancer 1 (2010), 764–778.
171. Tsai, W.C., Hsu, S.D., Hsu, C.S., Lai, T.C., Chen, S.J., Shen, R., et al. MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis. J. Clin. Invest. 122 (2012), 2884–2897.
172. Tu, B.P., Weissman, J.S., Oxidative protein folding in eukaryotes: mechanisms and consequences. J. Cell Biol. 164 (2004), 341–346.
173. Urano, F., Wang, X., Bertolotti, A., Zhang, Y., Chung, P., Harding, H.P., et al. Coupling of stress in the ER to activation of JNK protein kinases by transmembrane protein kinase IRE1. Science 287 (2000), 664–666.
174. Usui, M., Yamaguchi, S., Tanji, Y., Tominaga, R., Ishigaki, Y., Fukumoto, M., et al. Atf6alpha-null mice are glucose intolerant due to pancreatic beta-cell failure on a high-fat diet but partially resistant to diet-induced insulin resistance. Metabolism 61 (2012), 1118–1128.
175. Van Rooyen, D.M., Larter, C.Z., Haigh, W.G., Yeh, M.M., Ioannou, G., Kuver, R., et al. Hepatic free cholesterol accumulates in obese diabetic mice and causes nonalcoholic steatohepatitis. Gastroenterology 141 (2011), 1393–1403.
176. Vasudevan, S., Tong, Y., Steitz, J.A., Switching from repression to activation: microRNAs can up-regulate translation. Science 318 (2007), 1931–1934.
177. Vinciguerra, M., Sgroi, A., Veyrat-Durebex, C., Rubbia-Brandt, L., Buhler, L.H., Foti, M., Unsaturated fatty acids inhibit the expression of tumor suppressor phosphatase and tensin homolog (PTEN) via microRNA-21 up-regulation in hepatocytes. Hepatology 49 (2009), 1176–1184.
178. Wang, D., Wei, Y., Pagliassotti, M.J., Saturated fatty acids promote endoplasmic reticulum stress and liver injury in rats with hepatic steatosis. Endocrinology 147 (2006), 943–951.
179. Wang, C., Huang, Z., Du, Y., Cheng, Y., Chen, S., Guo, F., ATF4 regulates lipid metabolism and thermogenesis. Cell Res. 20 (2010), 174–184.
180. Wang, S., Chen, Z., Lam, V., Han, J., Hassler, J., Finck, B.N., et al. IRE1alpha-XBP1s induces PDI expression to increase MTP activity for hepatic VLDL assembly and lipid homeostasis. Cell Metab. 16 (2012), 473–486.
181. Wei, Y., Wang, D., Topczewski, F., Pagliassotti, M.J., Saturated fatty acids induce endoplasmic reticulum stress and apoptosis independently of ceramide in liver cells. Am. J. Physiol. Endocrinol. Metab. 291 (2006), E275–E281.
182. Wei, Y., Wang, D., Pagliassotti, M.J., Saturated fatty acid-mediated endoplasmic reticulum stress and apoptosis are augmented by trans-10, cis-12-conjugated linoleic acid in liver cells. Mol. Cell. Biochem. 303 (2007), 105–113.
183. Wieckowska, A., Zein, N.N., Yerian, L.M., Lopez, A.R., McCullough, A.J., Feldstein, A.E., In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease. Hepatology 44 (2006), 27–33.
184. Wiersma, H., Gatti, A., Nijstad, N., Oude Elferink, R.P., Kuipers, F., Tietge, U.J., Scavenger receptor class B type I mediates biliary cholesterol secretion independent of ATP-binding cassette transporter g5/g8 in mice. Hepatology 50 (2009), 1263–1272.
185. Wu, J., Kaufman, R.J., From acute ER stress to physiological roles of the Unfolded Protein Response. Cell Death Differ. 13 (2006), 374–384.
186. Xiao, G., Zhang, T., Yu, S., Lee, S., Calabuig-Navarro, V., Yamauchi, J., et al. ATF4 protein deficiency protects against high fructose-induced hypertriglyceridemia in mice. J. Biol. Chem. 288 (2013), 25350–25361.
187. Xu, C., Bailly-Maitre, B., Reed, J.C., Endoplasmic reticulum stress: cell life and death decisions. J. Clin. Invest. 115 (2005), 2656–2664.
188. Yamamoto, K., Takahara, K., Oyadomari, S., Okada, T., Sato, T., Harada, A., et al. Induction of liver steatosis and lipid droplet formation in ATF6alpha-knockout mice burdened with pharmacological endoplasmic reticulum stress. Mol. Biol. Cell 21 (2010), 2975–2986.
189. Yamaura, Y., Nakajima, M., Takagi, S., Fukami, T., Tsuneyama, K., Yokoi, T., Plasma microRNA profiles in rat models of hepatocellular injury, cholestasis, and steatosis. PLoS One, 7, 2012, e30250.
190. Yamazaki, H., Hiramatsu, N., Hayakawa, K., Tagawa, Y., Okamura, M., Ogata, R., et al. Activation of the Akt-NF-kappaB pathway by subtilase cytotoxin through the ATF6 branch of the unfolded protein response. J. Immunol. 183 (2009), 1480–1487.
191. Yang, Y., Jiang, Y., Wang, Y., An, W., Suppression of ABCA1 by unsaturated fatty acids leads to lipid accumulation in HepG2 cells. Biochimie 92 (2010), 958–963.
192. Yin, X.M., Ding, W.X., Gao, W.T., Autophagy in the liver. Hepatology 47 (2008), 1773–1785.
193. Yoneda, T., Imaizumi, K., Oono, K., Yui, D., Gomi, F., Katayama, T., et al. Activation of caspase-12, an endoplastic reticulum (ER) resident caspase, through tumor necrosis factor receptor-associated factor 2-dependent mechanism in response to the ER stress. J. Biol. Chem. 276 (2001), 13935–13940.
194. Zambo, V., Simon-Szabo, L., Szelenyi, P., Kereszturi, E., Banhegyi, G., Csala, M., Lipotoxicity in the liver. World J. Hepatol. 5 (2013), 550–557.
195. Zeng, L., Lu, M., Mori, K., Luo, S., Lee, A.S., Zhu, Y., et al. ATF6 modulates SREBP2-mediated lipogenesis. EMBO J. 23 (2004), 950–958.
196. Zhang, K., Wang, S., Malhotra, J., Hassler, J.R., Back, S.H., Wang, G., et al. The unfolded protein response transducer IRE1alpha prevents ER stress-induced hepatic steatosis. EMBO J. 30 (2011), 1357–1375.
197. Zhang, Y., Cheng, X., Lu, Z., Wang, J., Chen, H., Fan, W., et al. Upregulation of miR-15b in NAFLD models and in the serum of patients with fatty liver disease. Diabetes Res. Clin. Pract. 99 (2013), 327–334.
198. Zhang, W.G., Chen, L., Dong, Q., He, J., Zhao, H.D., Li, F.L., et al. Mmu-miR-702 functions as an anti-apoptotic mirtron by mediating ATF6 inhibition in mice. Gene 531 (2013), 235–242.
199. Zhang, X.Q., Xu, C.F., Yu, C.H., Chen, W.X., Li, Y.M., Role of endoplasmic reticulum stress in the pathogenesis of nonalcoholic fatty liver disease. World J. Gastroenterol. 20 (2014), 1768–1776.
200. Zhang, J., Li, Y., Jiang, S., Yu, H., An, W., Enhanced endoplasmic reticulum SERCA activity by overexpression of hepatic stimulator substance gene prevents hepatic cells from ER stress-induced apoptosis. Am. J. Physiol. Cell Physiol. 306 (2014), C279–C290.
201. Zhang, Q., Li, Y., Liang, T.T., Lu, X.M., Zhang, C., Liu, X.K., et al. ER stress and autophagy dysfunction contribute to fatty liver in diabetic mice. Int. J. Biol. Sci. 11 (2015), 559–568.
202. Zhang, K., Integration of ER stress, oxidative stress and the inflammatory response in health and disease. Int. J. Clin. Exp. Med. 3 (2010), 33–40.
203. Zhao, L., Chen, Y., Tang, R., Chen, Y., Li, Q., Gong, J., et al. Inflammatory stress exacerbates hepatic cholesterol accumulation via increasing cholesterol uptake and de novo synthesis. J. Gastroenterol. Hepatol. 26 (2011), 875–883.
204. Zheng, L., Lv, G.C., Sheng, J., Yang, Y.D., Effect of miRNA-10b in regulating cellular steatosis level by targeting PPAR-alpha expression, a novel mechanism for the pathogenesis of NAFLD. J. Gastroenterol. Hepatol. 25 (2010), 156–163.